Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Structure-based prediction of reversed-phase liquid chromatography retention time using machine-learning models built from miniature datasets.

Created on 18 Nov 2026

Authors

Jane Kawakami, Md Kamrul Hasan Khan, Yizhou Liu, Eric Dybeck, Doug Farrand, Bo Du, Iason Mustakis, Yu Zhang, Ke Wang

Published in

Analytica chimica acta. Volume 1428. Pages 346198. Dec 22, 2026. Epub Sep 07, 2026.

Abstract

Structure-based chromatographic retention prediction is critical for efficient method development and impurity characterization or monitoring in pharmaceutical analysis yet remains challenging without proper databases. Here, we present a practical project-specific quantitative structure-retention relationship (QSRR) framework that integrates descriptor fusion with a rigorously designed feature- and model-selection strategy to enable accurate retention time (RT) prediction using unfiltered miniature reversed-phase liquid chromatography (RPLC) datasets. Six molecular descriptor libraries, along with their various combinations, were evaluated using multiple machine learning algorithms within a nested cross-validation (CV) framework optimized to balance model fit and generalizability. The workflow was benchmarked using three late-stage Pfizer small-molecule projects, each comprising 17-21 compounds, including an externally validated set. High prediction accuracy was achieved across all case studies (R2 > 0.96, mean absolute percentage error < 9%), with absolute RT errors below 2.5 min (for analysis time ranging between 30 and 60 min) for all compounds in the EV set, including regioisomeric impurities. Notably, unlike the conventional localized QSRR modeling, the project-specific QSRR modeling does not require explicit structural similarity filtering because the compounds for model development and external validation are inherently chemically related.

PMID:
43045376
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement